To develop Casgevy, Vertex partnered with CRISPR Therapeutics, founded by Emmanuelle Charpentier, one of two scientists who won the Nobel Prize for the discovery of CRISPR technology as a gene editing ...

Private and public equity will usually be structured in the form of shares of stock in the company. The only distinction here is that public equity is raised by listing the company's shares on a ...